A new study on the racial differences in patient experience revealed black patients reported better experience than whites do, even though they were less likely to recommend hospitals.
A new study on the racial differences in patient experience revealed no major differences in terms of healthcare quality between blacks and whites. However, it was evident that within any given hospital black patients reported better experience than whites do, even if black patients were less likely to recommend hospitals.
Patient-reported experience is a critical part of measuring healthcare quality, but there is limited data on racial differences in patient experience. José F. Figueroa, MD, MPH, and colleagues at the Harvard T.H Chan School of Public Health, conducted this research by comparing blacks’ and whites’ responses on measures of overall hospital rating, communication, clinical processes, and hospital environment to evaluate differences between blacks’ and whites’ ratings of hospitals. The findings are published in Health Affairs.
Consumer Assessment
For the research, they used patient-level data obtained from the 2009 and 2010 Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) surveys of hospitals. Six composite measures (communication with physicians, communication with nurses, communication about medications, pain control, discharge process, and staff responsiveness) were recorded to evaluate 2 global measures related to patient experience:
Only patients who identified themselves as black or white were included. No Hispanics or minority groups were included.
Study Results
Out of the 4,365,175 respondents to the survey, 9.8% were blacks and 90.2% were whites. Compared with white patients, black patients were more likely to be younger than age 65, female, report their health status as fair or poor, and have been admitted for a medical reason, plus they were less likely to have graduated from high school.
When examined for the measures of clinical care, there were no significant differences in the responses between the blacks and whites. However, the researchers found:
In general, blacks reported more positive experiences—though by a small margin—than whites across all measures.
Conclusion
Patient-reported experience in healthcare is a crucial quality metric. Payers and policy makers are increasingly using this metric to hold hospitals accountable. One area of particular concern is racial disparities in patients’ experiences. In light of these racial disparities, increasing attention should be diverted to cultural competency training to improve care delivered to minority patients.
“Previous work has shown that distrust of the healthcare system is associated with lower rates of recommended disease prevention and treatment of acute and chronic illness, as well as worse health status,” the authors concluded. “It is critically important to understand both the extent to which black patients may have differences in experience with hospital care and how those differences might be addressed.”
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More